Regeneron Pharmaceuticals, Inc. (REGN)
Last Price$700.30.6%
Market Cap$75.4B
REGN Rating
Crunching data... Almost there!
REGN Intrinsic Value
Crunching data... Almost there!
REGN Share Price History
1W 4.0%
1M 1.8%
6M (40.9%)
YTD (22.6%)
1Y (26.5%)
3Y 16.2%
5Y 73.7%
10Y 64.7%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
REGN Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!
REGN Stock Financials
REGN Income Statement Metrics
Crunching data... Almost there!
REGN Cash Flow Statement Metrics
Crunching data... Almost there!
REGN Income Statement Overview
Crunching data... Almost there!
REGN Balance Sheet Overview
Crunching data... Almost there!
REGN Stock Ratios
Crunching data... Almost there!
REGN Earnings Surprises
Crunching data... Almost there!
REGN Dividends
REGN Dividend Yield
Crunching data... Almost there!
REGN Dividend Per Share
Crunching data... Almost there!
Competing with REGN
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is Regeneron Pharmaceuticals, Inc. (REGN) stock rating?
As of today, Regeneron Pharmaceuticals, Inc. has a stock rating of 7 (out of 10), which is considered Good.
is Regeneron Pharmaceuticals, Inc. (REGN) a good stock to buy?
As of today, Regeneron Pharmaceuticals, Inc. has a Good stock rating, which is 39.9% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.